We found that the aggressive clones derived from the CD49f+/CD44+/CD24− DCIS stem cell population had higher ALDH1 activity, lower global DNA methylation and expressed significantly higher levels of stem cell related proteins such as SOX2, OCT4 and SOX9. The gene discussed is CD44; the disease is ductal breast carcinoma in situ.